
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
LIT-001, the First Nonpeptide Oxytocin Receptor Agonist that Improves Social Interaction in a Mouse Model of Autism
Marie‐Céline Frantz, Lucie P. Pellissier, Elsa Pflimlin, et al.
Journal of Medicinal Chemistry (2018) Vol. 61, Iss. 19, pp. 8670-8692
Open Access | Times Cited: 47
Marie‐Céline Frantz, Lucie P. Pellissier, Elsa Pflimlin, et al.
Journal of Medicinal Chemistry (2018) Vol. 61, Iss. 19, pp. 8670-8692
Open Access | Times Cited: 47
Showing 1-25 of 47 citing articles:
Effects of ketamine on rat social behavior as analyzed by DeepLabCut and SimBA deep learning algorithms
Piotr Popik, Ewelina Cyrano, Diana Piotrowska, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 8
Piotr Popik, Ewelina Cyrano, Diana Piotrowska, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 8
Challenges and Opportunities in Central Nervous System Drug Discovery
Jonathan J. Danon, Tristan A. Reekie, Michael Kassiou
Trends in Chemistry (2019) Vol. 1, Iss. 6, pp. 612-624
Open Access | Times Cited: 69
Jonathan J. Danon, Tristan A. Reekie, Michael Kassiou
Trends in Chemistry (2019) Vol. 1, Iss. 6, pp. 612-624
Open Access | Times Cited: 69
The role of oxytocin in alcohol and drug abuse
Courtney King, Anny Gano, Howard C. Becker
Brain Research (2020) Vol. 1736, pp. 146761-146761
Open Access | Times Cited: 60
Courtney King, Anny Gano, Howard C. Becker
Brain Research (2020) Vol. 1736, pp. 146761-146761
Open Access | Times Cited: 60
Synthesis of pyrazolone fused benzodiazepines via Rh(iii )-catalyzed [4 + 3] annulation of 1-phenylpyrazolidinones with propargyl alcohols
Linghua Zhang, Yuanshuang Xu, Xiaopeng Zhang, et al.
Organic Chemistry Frontiers (2020) Vol. 7, Iss. 16, pp. 2284-2290
Closed Access | Times Cited: 56
Linghua Zhang, Yuanshuang Xu, Xiaopeng Zhang, et al.
Organic Chemistry Frontiers (2020) Vol. 7, Iss. 16, pp. 2284-2290
Closed Access | Times Cited: 56
Oxytocin and vasopressin signaling in health and disease
Monika Perisic, Katrina Woolcock, Anke Hering, et al.
Trends in Biochemical Sciences (2024) Vol. 49, Iss. 4, pp. 361-377
Open Access | Times Cited: 7
Monika Perisic, Katrina Woolcock, Anke Hering, et al.
Trends in Biochemical Sciences (2024) Vol. 49, Iss. 4, pp. 361-377
Open Access | Times Cited: 7
Targeting the Oxytocin System: New Pharmacotherapeutic Approaches
Damien W. Gulliver, Eryn L. Werry, Tristan A. Reekie, et al.
Trends in Pharmacological Sciences (2018) Vol. 40, Iss. 1, pp. 22-37
Open Access | Times Cited: 50
Damien W. Gulliver, Eryn L. Werry, Tristan A. Reekie, et al.
Trends in Pharmacological Sciences (2018) Vol. 40, Iss. 1, pp. 22-37
Open Access | Times Cited: 50
A Nonpeptide Oxytocin Receptor Agonist for a Durable Relief of Inflammatory Pain
Louis Hilfiger, Qian Zhao, Damien Kerspern, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 41
Louis Hilfiger, Qian Zhao, Damien Kerspern, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 41
Catalytic System‐Controlled Divergent Reaction Strategies for the Construction of Diversified Spiropyrazolone Skeletons from Pyrazolidinones and Diazopyrazolones
Feifei Fang, Shulei Hu, Chunpu Li, et al.
Angewandte Chemie International Edition (2021) Vol. 60, Iss. 39, pp. 21327-21333
Closed Access | Times Cited: 34
Feifei Fang, Shulei Hu, Chunpu Li, et al.
Angewandte Chemie International Edition (2021) Vol. 60, Iss. 39, pp. 21327-21333
Closed Access | Times Cited: 34
Structural basis for the activation and ligand recognition of the human oxytocin receptor
Yann Waltenspühl, Janosch Ehrenmann, Santiago Vacca, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 23
Yann Waltenspühl, Janosch Ehrenmann, Santiago Vacca, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 23
Towards the convergent therapeutic potential of G protein‐coupled receptors in autism spectrum disorders
Anil Annamneedi, Caroline Gora, Ana Dudas, et al.
British Journal of Pharmacology (2023)
Open Access | Times Cited: 15
Anil Annamneedi, Caroline Gora, Ana Dudas, et al.
British Journal of Pharmacology (2023)
Open Access | Times Cited: 15
Antidepressant- and anxiolytic-like activities of Rosmarinus officinalis extract in rodent models: Involvement of oxytocinergic system
Kazunori Sasaki, Farhana Ferdousi, Satoshi Fukumitsu, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 144, pp. 112291-112291
Open Access | Times Cited: 28
Kazunori Sasaki, Farhana Ferdousi, Satoshi Fukumitsu, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 144, pp. 112291-112291
Open Access | Times Cited: 28
Benzodiazepine Derivatives as Potent Vasopressin V2 Receptor Antagonists for the Treatment of Autosomal Dominant Kidney Disease
Xudong Cao, Peng Wang, Haoxing Yuan, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 13, pp. 9295-9311
Closed Access | Times Cited: 19
Xudong Cao, Peng Wang, Haoxing Yuan, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 13, pp. 9295-9311
Closed Access | Times Cited: 19
G protein–coupled receptor endocytosis generates spatiotemporal bias in β-arrestin signaling
A. Tóth, Bence Szalai, Orsolya Tünde Kovács, et al.
Science Signaling (2024) Vol. 17, Iss. 842
Closed Access | Times Cited: 4
A. Tóth, Bence Szalai, Orsolya Tünde Kovács, et al.
Science Signaling (2024) Vol. 17, Iss. 842
Closed Access | Times Cited: 4
Tuning Properties for Blood–Brain Barrier Permeation: A Statistics-Based Analysis
Maria Dichiara, Benedetto Amata, Rita Turnaturi, et al.
ACS Chemical Neuroscience (2019) Vol. 11, Iss. 1, pp. 34-44
Closed Access | Times Cited: 30
Maria Dichiara, Benedetto Amata, Rita Turnaturi, et al.
ACS Chemical Neuroscience (2019) Vol. 11, Iss. 1, pp. 34-44
Closed Access | Times Cited: 30
Role of Oxytocin and Vasopressin in Neuropsychiatric Disorders: Therapeutic Potential of Agonists and Antagonists
Valeska Cid-Jofré, Macarena Moreno, Miguel Reyes‐Parada, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 12077-12077
Open Access | Times Cited: 25
Valeska Cid-Jofré, Macarena Moreno, Miguel Reyes‐Parada, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 12077-12077
Open Access | Times Cited: 25
Structures of the arginine-vasopressin and oxytocin receptor signaling complexes
Julien Bous, Aurélien Fouillen, Hélène Orcel, et al.
Vitamins and hormones (2023), pp. 67-107
Closed Access | Times Cited: 8
Julien Bous, Aurélien Fouillen, Hélène Orcel, et al.
Vitamins and hormones (2023), pp. 67-107
Closed Access | Times Cited: 8
Oxytocin Ameliorates Impaired Behaviors of High Fat Diet-Induced Obese Mice
Ryotaro Hayashi, Yoshiyuki Kasahara, Shizu Hidema, et al.
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 21
Ryotaro Hayashi, Yoshiyuki Kasahara, Shizu Hidema, et al.
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 21
A CO2-Catalyzed Transamidation Reaction
Yang Yang, Jian Liu, Fadhil S. Kamounah, et al.
The Journal of Organic Chemistry (2021) Vol. 86, Iss. 23, pp. 16867-16881
Closed Access | Times Cited: 18
Yang Yang, Jian Liu, Fadhil S. Kamounah, et al.
The Journal of Organic Chemistry (2021) Vol. 86, Iss. 23, pp. 16867-16881
Closed Access | Times Cited: 18
Oxytocin promotes epicardial cell activation and heart regeneration after cardiac injury
Aaron H. Wasserman, Amanda Huang, Yonatan R. Lewis‐Israeli, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 13
Aaron H. Wasserman, Amanda Huang, Yonatan R. Lewis‐Israeli, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 13
Effects of oxytocin receptor agonists on hair growth promotion
Tatsuto Kageyama, Jieun Seo, Lei Yan, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Tatsuto Kageyama, Jieun Seo, Lei Yan, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Interactions of Oxytocin and Dopamine—Effects on Behavior in Health and Disease
Maria Petersson, Kerstin Uvnäs‐Moberg
Biomedicines (2024) Vol. 12, Iss. 11, pp. 2440-2440
Open Access | Times Cited: 2
Maria Petersson, Kerstin Uvnäs‐Moberg
Biomedicines (2024) Vol. 12, Iss. 11, pp. 2440-2440
Open Access | Times Cited: 2
Biased activation of the vasopressin V2 receptor probed by molecular dynamics simulations, NMR and pharmacological studies.
Aurélien Fouillen, Pierre Couvineau, Gérald Gaibelet, et al.
Computational and Structural Biotechnology Journal (2024) Vol. 23, pp. 3784-3799
Open Access | Times Cited: 2
Aurélien Fouillen, Pierre Couvineau, Gérald Gaibelet, et al.
Computational and Structural Biotechnology Journal (2024) Vol. 23, pp. 3784-3799
Open Access | Times Cited: 2
Male-selective effects of oxytocin agonism on alcohol intake: behavioral assessment in socially housed prairie voles and involvement of RAGE
Sheena Potretzke, Yangmiao Zhang, L. Ju, et al.
Neuropsychopharmacology (2022) Vol. 48, Iss. 6, pp. 920-928
Open Access | Times Cited: 11
Sheena Potretzke, Yangmiao Zhang, L. Ju, et al.
Neuropsychopharmacology (2022) Vol. 48, Iss. 6, pp. 920-928
Open Access | Times Cited: 11
An Approach to Pharmacological Targets of Pyrrole Family From Medicinal Chemistry Viewpoint
Mohsen Amini, Ebrahim Saeedian Moghadam, Katayoon Mireskandari, et al.
Mini-Reviews in Medicinal Chemistry (2022) Vol. 22, Iss. 19, pp. 2486-2561
Closed Access | Times Cited: 9
Mohsen Amini, Ebrahim Saeedian Moghadam, Katayoon Mireskandari, et al.
Mini-Reviews in Medicinal Chemistry (2022) Vol. 22, Iss. 19, pp. 2486-2561
Closed Access | Times Cited: 9
In vitro and in vivo Biological Evaluation of Newly Tacrine-Selegiline Hybrids as Multi-Target Inhibitors of Cholinesterases and Monoamine Oxidases for Alzheimer’s Disease
S.C. Huang, Jinchong Luo, Guohui Zhong, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 133-159
Open Access | Times Cited: 1
S.C. Huang, Jinchong Luo, Guohui Zhong, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 133-159
Open Access | Times Cited: 1